7The sterol response element binding protein regulates cyclooxygenase-2 gene expression in endothelial cells

Journal of Lipid Research

Volumn 46, Issue 5, 2005, Pages 862-871

  Smith, Layton Harris ^a   Petrie, Matthew S ^b   Morrow, Jason D ^b   Oates, John A ^b   Vaughan, Douglas E ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cholesterol; HMG CoA reductase inhibitor; Lovastatin; Prostacyclin; Vascular endothelial function

Indexed keywords

CHOLESTEROL; CYCLOOXYGENASE 2; LOW DENSITY LIPOPROTEIN RECEPTOR; LUCIFERASE; PROSTACYCLIN; STEROL REGULATORY ELEMENT BINDING PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1A; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; CCAAT ENHANCER BINDING PROTEIN; DNA BINDING PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEMBRANE PROTEIN; MEVINOLIN; PRIMER DNA; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN; SREBF1 PROTEIN, HUMAN; SREBF2 PROTEIN, HUMAN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; ANIMAL; BIOSYNTHESIS; CATTLE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

ANIMALS; BASE SEQUENCE; CATTLE; CCAAT-ENHANCER-BINDING PROTEINS; CELLS, CULTURED; CYCLOOXYGENASE 2; DNA PRIMERS; DNA-BINDING PROTEINS; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; MEMBRANE PROTEINS; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRANSCRIPTION FACTORS;

EID: 27244434926     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M500021-JLR200     Document Type: Article

References (57)

1. Tyroler, H. A. 1985. Total serum cholesterol and ischemic heart disease risk in clinical trials and observational studies. Am. J. Prev. Med. 1: 18-24.
2. Vogel, R. A. 1999. Cholesterol lowering and endothelial function. Am. J. Med. 107: 479-487.
3. Camacho, M., J. Lopez-Belmonte, and L. Vila. 1998. Rate of vasoconstrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and prostaglandin I synthase activity. Circ. Res. 83: 353-365.
4. Creminon, C., A. Habib, J. Maclouf, P. Pradelles, J. Grassi, and Y. Frobert. 1995. Differential measurement of constitutive (COX-1) and inducible (COX-2) cyclooxygenase expression in human umbilical vein endothelial cells using specific immunometric enzyme immunoassays. Biochim. Biophys. Acta. 1254: 341-348.
5. Hammon, J. W., and J. A. Oates. 1986. Interaction of platelets with the vessel wall in the pathophysiology of sudden cardiac death. Circulation. 73: 224-226.
6. Cheng, Y., S. C. Austin, B. Rocca, B. H. Koller, T. M. Coffman, T. Grosser, J. A. Lawson, and G. A. FitzGerald. 2002. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science. 296: 539-541.
7. Oates, J. A., G. A. FitzGerald, R. A. Branch, E. K. Jackson, H. R. Knapp, and L. J. Roberts II. 1988. Clinical implications of prostaglandin and thromboxane A2 formation (1). N. Engl. J. Med. 319: 689-698.
8. Fitzgerald, D. J., L. Roy, F. Catella, and G. A. FitzGerald. 1986. Platelet activation in unstable coronary disease. N. Engl. J. Med. 315: 983-989.
9. Brown, M. S. 1985. A receptor-mediated pathway for cholesterol homeostasis. J. Cell Sci. 3 (Suppl.): 131-137.
10. Horton, J. D., J. L. Goldstein, and M. S. Brown. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109: 1125-1131.
11. Shimano, H. 2001. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog. Lipid Res. 40: 439-452.
12. Brown, M. S., and J. L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science. 232: 34-47.
13. Goldstein, J. L., and M. S. Brown. 1990. Regulation of the mevalonate pathway. Nature. 343: 425-430.
14. Briggs, M. R., C. Yokoyama, X. Wang, M. S. Brown, and J. L. Goldstein. 1993. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence. J. Biol. Chem. 268: 14490-14496.
15. Sakai, J., A. Nohturfft, D. Cheng, Y. K. Ho, M. S. Brown, and J. L. Goldstein. 1997. Identification of complexes between the COOH-terminal domains of sterol regulatory element-binding proteins (SREBPs) and SREBP cleavage-activating protein. J. Biol. Chem. 272: 20213-20221.
16. Sakai, J., E. A. Duncan, R. B. Rawson, X. Hua, M. S. Brown, and J. L. Goldstein. 1996. Sterol-regulated release of SREBP-2 from cell membranes requires two sequential cleavages, one within a transmembrane segment. Cell. 85: 1037-1046.
17. Horton, J. D., J. L. Goldstein, M. S. Brown, and R. B. Rawson. 2003. Combined analysis of oligonucleotide microarray data from transgenic mice identifies direct SREBP target genes. Proc. Natl. Acad. Sci. USA. 100: 12027-12032.
18. Korn, B. S., I. Shimomura, Y. Bashmakov, R. E. Hammer, J. D. Horton, J. L. Goldstein, and M. S. Brown. 1998. Blunted feedback suppression of SREBP processing by dietary cholesterol in transgenic mice expressing sterol-resistant SCAP(D443N). J. Clin. Invest. 102: 2050-2060.
19. Smith, L. H., O. Boutaud, M. Breyer, J. D. Morrow, J. A. Oates, and D. E. Vaughan. 2002. Cyclooxygenase-2-dependent prostacyclin formation is regulated by low density lipoprotein cholesterol in vitro. Arterioscler. Thromb. Vasc. Biol. 22: 983-988.
20. Shimomura, I., H. Shimano, B. S. Korn, Y. Bashmakov, and J. D. Horton. 1998. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J. Biol. Chem. 273: 35299-35306.
21. Inoue, H., T. Nanayama, S. Hara, C. Yokoyama, and T. Tanabe. 1994. The cyclic AMP response element plays an essential role in the expression of the human prostaglandin-endoperoxide synthase 2 gene in differentiated U937 monocytic cells. FEBS Lett. 350: 51-54.
22. Meade, E. A., T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott. 1999. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J. Biol. Chem. 274: 8328-8334.
23. Gimbrone, M. A., Jr. 1976. Culture of vascular endothelium. Prog. Hemost. Thromb. 3: 1-28.
24. Booyse, F. M., B. J. Sedlak, and M. E. Rafelson, Jr. 1975. Culture of arterial endothelial cells: characterization and growth of bovine aortic cells. Thromb. Diath. Haemorrh. 34: 825-839.
25. Vaughan, D. E., J. L. Rouleau, and M. A. Pfeffer. 1995. Role of the fibrinolytic system in preventing myocardial infarction. Eur. Heart J. 16 (Suppl. K): 31-36.
26. Venkov, C. D., A. B. Rankin, and D. E. Vaughan. 1996. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation. 94: 727-733.
27. Sambrook, J., D. W. Russell. 2001. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
28. Fon Tacer, K., S. Kalanj-Bognar, M. R. Waterman, and D. Rozman. 2003. Lanosterol metabolism and sterol regulatory element binding protein (SREBP) expression in male germ cell maturation. J. Steroid Biochem. Mol. Biol. 85: 429-438.
29. Smith, J. R., T. F. Osborne, J. L. Goldstein, and M. S. Brown. 1990. Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene. J. Biol. Chem. 265: 2306-2310.
30. Knott, I., M. Raes, M. Dieu, G. Lenoir, M. Burton, and J. Remacle. 1993. Routine prostaglandin assay by GC-MS in multiwell tissue culture plates: application to human synoviocytes and chondrocytes. Anal. Biochem. 210: 360-365.
31. Daniel, V. C., T. A. Minton, N. J. Brown, J. H. Nadeau, and J. D. Morrow. 1994. Simplified assay for the quantification of 2,3-dinor-6-keto-prostaglandin F1 alpha by gas chromatography-mass spectrometry. J. Chromatogr. B Biomed. Appl. 653: 117-122.
32. Smith L. H., S. R. Coats, H. Qin, M. S. Petrie, J. W. Covington, M. Su, M. Eren, and D. E. Vaughan. 2004. Differential and opposing regulation of PAI-1 promoter activity by estrogen receptor alpha and estrogen receptor beta in endothelial cells. Circ. Res. 95: 269-275.
33. Ye, J., U. P. Dave, N. V. Grishin, J. L. Goldstein, and M. S. Brown. 2000. Asparagine-proline sequence within membrane-spanning segment of SREBP triggers intramembrane cleavage by site-2 protease. Proc. Natl. Acad. Sci. USA. 97: 5123-5128.
34. Guan, G., P. H. Dai, T. F. Osborne, J. B. Kim, and I. Shechter. 1997. Multiple sequence elements are involved in the transcriptional regulation of the human squalene synthase gene. J. Biol. Chem. 272: 10295-10302.
35. Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, Goldstein JL, Brown MS. 1993. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell. 75: 187-197.
36. Annicotte, J. S., K. Schoonjans, C. Haby, and J. Auwerx. 2001. An E-box in pGL3 reporter vectors precludes their use for the study of sterol regulatory element-binding proteins. Biotechniques. 31: 993-994.
37. Lind, L. 2002. Lipids and endothelium-dependent vasodilation - a review. Lipids. 37: 1-15.
38. Dart, A. M., and J. P. Chin-Dusting. 1999. Lipids and the endothelium. Cardiovasc. Res. 43: 308-322.
39. Werstuck, G. H., S. R. Lentz, S. Dayal, G. S. Hossain, S. K. Sood, Y. Y. Shi, J. Zhou, N. Maeda, S. K. Krisans, M. R. Malinow, and R. C. Austin. 2001. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J. Clin. Invest. 107: 1263-1273.
40. Jackson, B. A., R. H. Goldstein, R. Roy, M. Cozzani, L. Taylor, and P. Polgar. 1993. Effects of transforming growth factor beta and interleukin-1 beta on expression of cyclooxygenase 1 and 2 and phospholipase A2 mRNA in lung fibroblasts and endothelial cells in culture. Biochem. Biophys. Res. Commun. 197: 1465-1474.
41. Hajjar, D. P., B. B. Weksler, D. J. Falcone, J. M. Hefton, K. Tack-Goldman, and C. R. Minick. 1982. Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells. J. Clin. Invest. 70: 479-488.
42. Pomerantz, K. B., A. R. Tall, S. J. Feinmark, and P. J. Cannon. 1984. Stimulation of vascular smooth muscle cell prostacyclin and prostaglandin E2 synthesis by plasma high and low density lipoproteins. Circ. Res. 54: 554-565.
43. Wilson, S. H., R. D. Simari, P. J. Best, T. E. Peterson, L. O. Lerman, M. Aviram, K. A. Nath, D. R. Holmes, Jr., and A. Lerman. 2001. Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering. Arterioscler. Thromb. Vasc. Biol. 21: 122-128.
44. Grodos, D., and R. Tonglet. 1994. Scandinavian simvastatin study (4S). Lancet. 344: 1768.
45. Group, T. L. S. 1998. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N. Engl. J. Med. 339: 1349-1357.
46. Huttunen, J. K., M. H. Frick, O. P. Heinonen, P. Heinsalmi, V. Manninen, M. Manttari, and M. Romo. 1988. Helsinki Heart Study. New perspectives in the prevention of coronary heart disease. Drugs. 36 (Suppl. 3): 32-36.
47. Aengevaeren, W. R. 1999. Beyond lipids - the role of the endothelium in coronary artery disease. Atherosclerosis. 147 (Suppl. 1): 11-16.
48. Lewis, S. J., L. A. Moye, F. M. Sacks, D. E. Johnstone, G. Timmis, J. Mitchell, M. Limacher, S. Kell, S. P. Glasser, J. Grant, B. R. Davis, M. A. Pfeffer, and E. Braunwald. 1998. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann. Intern. Med. 129: 681-689.
49. Gotto, A. M., Jr. 1998. The Lipoprotein and Coronary Atherosclerosis Study (LCAS) in context: assessing the benefits of lipid-lowering therapy. Introduction. Am. J. Cardiol. 82: 1M.
50. Downs, J. R., M. Clearfield, S. Weis, E. Whitney, D. R. Shapiro, P. A. Beere, A. Langendorfer, E. A. Stein, W. Kruyer, and A. M. Gotto, Jr. 1998. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. J. Am. Med. Assoc. 279: 1615-1622.
51. Liao, J. K., and D. J. Maron. 2001. Current perspectives on statins. Arterioscler. Thromb. Vasc. Biol. 21: 1712-1719.
52. Yang J., J. L. Goldstein, R. E. Hammer, Y. A. Moon, M. S. Brown, and J. D. Horton. 2001. Decreased lipid synthesis in livers of mice with disrupted site-1 protease gene. Proc. Natl. Acad. Sci. USA. 98: 13607-13612.
53. Inoue, J., H. Kumagai, T. Terada, M. Maeda, M. Shimizu, and R. Sato. 2001. Proteolytic activation of SREBPs during adipocyte differentiation. Biochem. Biophys. Res. Commun. 283: 1157-1161.
54. Tabor, D. E., J. B. Kim, B. M. Spiegelman, and P. A. Edwards. 1999. Identification of conserved cis-elements and transcription factors required for sterol-regulated transcription of stearoyl-CoA desaturase 1 and 2. J. Biol. Chem. 274: 20603-20610.
55. Smith, J. R., T. F. Osborne, M. S. Brown, J. L. Goldstein, and G. Gil. 1988. Multiple sterol regulatory elements in promoter for hamster 3-hydroxy-3-methylglutaryl-coenzyme A synthase. J. Biol. Chem. 263: 18480-18487.
56. Sato, R., J. Inoue, Y. Kawabe, T. Kodama, T. Takano, and M. Maeda. 1996. Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2. J. Biol. Chem. 271: 26461-26464.
57. Ericsson, J., S. M. Jackson, J. B. Kim, B. M. Spiegelman, and P. A. Edwards. 1997. Identification of glycerol-3-phosphate acyltransferase as an adipocyte determination and differentiation factor 1- and sterol regulatory element-binding protein-responsive gene. J. Biol. Chem. 272: 7298-7305.